» Articles » PMID: 36555670

From Low-Grade Inflammation in Osteoarthritis to Neuropsychiatric Sequelae: A Narrative Review

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Dec 23
PMID 36555670
Authors
Affiliations
Soon will be listed here.
Abstract

Nowadays, osteoarthritis (OA), a common, multifactorial musculoskeletal disease, is considered to have a low-grade inflammatory pathogenetic component. Lately, neuropsychiatric sequelae of the disease have gained recognition. However, a link between the peripheral inflammatory process of OA and the development of neuropsychiatric pathology is not completely understood. In this review, we provide a narrative that explores the development of neuropsychiatric disease in the presence of chronic peripheral low-grade inflammation with a focus on its signaling to the brain. We describe the development of a pro-inflammatory environment in the OA-affected joint. We discuss inflammation-signaling pathways that link the affected joint to the central nervous system, mainly using primary sensory afferents and blood circulation via circumventricular organs and cerebral endothelium. The review describes molecular and cellular changes in the brain, recognized in the presence of chronic peripheral inflammation. In addition, changes in the volume of gray matter and alterations of connectivity important for the assessment of the efficacy of treatment in OA are discussed in the given review. Finally, the narrative considers the importance of the use of neuropsychiatric diagnostic tools for a disease with an inflammatory component in the clinical setting.

Citing Articles

Interconnected Pathways: Exploring Inflammation, Pain, and Cognitive Decline in Osteoarthritis.

Tarasovs M, Skuja S, Svirskis S, Sokolovska L, Vikmanis A, Lejnieks A Int J Mol Sci. 2024; 25(22).

PMID: 39595987 PMC: 11594107. DOI: 10.3390/ijms252211918.


Estimating the impact of metabolic syndrome on low back pain and the joint effects of metabolic syndrome and depressive symptoms on low back pain: insights from the China Health and Retirement Longitudinal Study.

Huang J, Peng D, Wang X BMC Public Health. 2024; 24(1):2359.

PMID: 39215306 PMC: 11363518. DOI: 10.1186/s12889-024-19851-6.


Obesity, Metabolic Syndrome, and Osteoarthritis Require Integrative Understanding and Management.

Mocanu V, Timofte D, Zara-Danceanu C, Labusca L Biomedicines. 2024; 12(6).

PMID: 38927469 PMC: 11201254. DOI: 10.3390/biomedicines12061262.


PSD95 as a New Potential Therapeutic Target of Osteoarthritis: A Study of the Identification of Hub Genes through Self-Contrast Model.

Huang P, Lin J, Shen H, Zhao X Int J Mol Sci. 2023; 24(19).

PMID: 37834131 PMC: 10572132. DOI: 10.3390/ijms241914682.


Identification of Novel Diagnostic Biomarkers and Classification Patterns for Osteoarthritis by Analyzing a Specific Set of Genes Related to Inflammation.

Li S, Ma L, Cui R Inflammation. 2023; 46(6):2193-2208.

PMID: 37462886 DOI: 10.1007/s10753-023-01871-w.

References
1.
Jones Amaowei E, Anwar S, Kavanoor Sridhar K, Shabbir K, Mohammed E, Bahar A . Correlation of Depression and Anxiety With Rheumatoid Arthritis. Cureus. 2022; 14(3):e23137. PMC: 9009973. DOI: 10.7759/cureus.23137. View

2.
Eskilsson A, Shionoya K, Engblom D, Blomqvist A . Fever During Localized Inflammation in Mice Is Elicited by a Humoral Pathway and Depends on Brain Endothelial Interleukin-1 and Interleukin-6 Signaling and Central EP Receptors. J Neurosci. 2021; 41(24):5206-5218. PMC: 8211540. DOI: 10.1523/JNEUROSCI.0313-21.2021. View

3.
Mason A, Holmes C, Edwards C . Inflammation and dementia: Using rheumatoid arthritis as a model to develop treatments?. Autoimmun Rev. 2018; 17(9):919-925. DOI: 10.1016/j.autrev.2018.04.001. View

4.
Mailhot B, Christin M, Tessandier N, Sotoudeh C, Bretheau F, Turmel R . Neuronal interleukin-1 receptors mediate pain in chronic inflammatory diseases. J Exp Med. 2020; 217(9). PMC: 7478735. DOI: 10.1084/jem.20191430. View

5.
Kis B, Isse T, Snipes J, Chen L, Yamashita H, Ueta Y . Effects of LPS stimulation on the expression of prostaglandin carriers in the cells of the blood-brain and blood-cerebrospinal fluid barriers. J Appl Physiol (1985). 2005; 100(4):1392-9. DOI: 10.1152/japplphysiol.01259.2005. View